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Abstract Persistent urinary tract infections (UTI) are
often caused by E. coli adhered to urothelium. This type of
cells is generally recognized as very tolerant to antibiotics
which renders difficult the treatment of chronic UTI. This
study investigates the use of lytic bacteriophages as alter-
native antimicrobial agents, particularly the interaction of
phages with E. coli adhered to urothelium and specifically
determines their efficiency against this type of cells. The
bacterial adhesion to urothelium was performed varying
the bacterial cell concentrations and the period and con-
ditions (static, shaken) of adhesion. Three collection bac-
teriophages (T1, T4, and phiX174 like phages) were tested
against clinical E. coli isolates and only one was selected
for further infection experiments. Based on the lytic
spectrum against clinical isolates and its ability to infect
the highest number of antibiotic resistant strains, the T1-
like bacteriophage was selected. This bacteriophage caused
nearly a 45% reduction of the bacterial population after
2 h of treatment. This study provides evidence that
bacteriophages are effective in controlling suspended and
adhered cells and therefore can be a viable alternative to
antibiotics to control urothelium- adhered bacteria.
Introduction
In the recent years, there has been a spread of multidrug
resistant bacteria, including bacteria resistant to the last
resort antibiotics [1]. Therefore, prevention and control of
bacterial resistance requires new antimicrobial agents, the
prudent use of existing ones, new vaccines and enhanced
public health efforts to reduce transmission of bacterial
resistance. Also, the use of bacteriophages as an alterna-
tive to antibiotherapy is again redrawing attention. A
considerable number of publications demonstrate that
phage preparations for veterinary purposes can efficiently
control the bacterial loads in infected animals [2–5] and
strongly supports the concept of phage therapy as an
alternative or complementary strategy to antibiotherapy.
Furthermore, orally administered phages have been
recovered from the blood and physical fluids, including
urine [6, 7] and phages administered by intraperitoneal
injection have been detected in different organs, such as:
liver, kidneys, spleen, lungs, muscles, brain, and blood [8].
Despite these attractive characteristics, there is limited
information on phage infection of bacteria adhered to
epithelial cells. The study described herein focuses the
efficacy of phage to kill its target host when the last is
found adhered to urothelium. For this, the efficacy of three
DSMZ collection phages (T1, T4 and phiX174) against a
pool of 69 E. coli strains isolated from urinary tract
infections was studied and only the broadest host range
phage was used to perform the infection experiments with
suspended or urothelium adhered E. coli.
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Materials and Methods
Bacteria, Bacteriophage, and Media
The bacteriophages and respective hosts were purchased
from the Deutsche Sammlung von Mikroorganismen und
Zellkulturen (DSMZ), Germany. Both bacteriophages T1
(DSM 5801) and T4 (DSM 4505) have as host Escherichia
coli DSM 613, while phage phiX174 (DSM 4497) has
ashost E. coli DSM 13127. The media used for E. coli
growth were either LB media or artificial urine (0.65 gl-1
of Magnesium chloride hexahydrate, 0.65 g l-1 of Calcium
chloride monohydrated, 4.6 g l-1 of sodium chloride,
2.3 g l-1 of sodium sulfate, 0.65 g l-1 of Sodium Citrate
dihydrated, 0.20 g l-1 of Disodium oxalate, 2.8 g l-1 of
potassium dihydrogen phosphate, 1.6 g l-1 of potassium
chloride, 2.0 g l-1 of NH4Cl, 12 g l-1 of Urea, 1.1 g l-1
of Creatinin, 0.1 g l-1 of Tryptic Soy Broth (TSB)). Pha-
ges were propagated in MGC media (5.0 g/l of peptone,
3.0 g/l of meet extract and 0.8 g/l of NaCl). The clinical
isolates of E. coli used in this study, were isolated from
patients with urinary tract infections.
Lytic Spectra of the Phages and Selection
of the Broadest Host Range Phage
The three phages (T1, T4, and phiX174) were tested
against the 69 clinical E. coli isolates using the phage
spot test procedure [9]. In brief, 3 ml of MGC top-agar
(MGC media with 0.6% agar) were added to 100 ll
overnight cultures of each clinical isolate and poured onto
a dish containing MGC agar (MGC media with 1.2%
agar). The agar was allowed to solidify after which 10 ll
each phage was spotted on the bacterial lawn of the dif-
ferent isolates. The drop was allowed to dry and the
plates were incubated overnight at 37C. Phage sensitive
E. coli showed clear or turbid areas where the phage
solutions were spotted.
Antibiotic Sensitivity Test
The susceptibility of the 69 E. coli clinical isolates to eight
antimicrobial agents was determined by the disc diffusion
method on modified Mueller–Hinton II agar according to
the European Committee on Antimicrobial Susceptibility
Testing (EUCAST).
Stability of Phage in Artificial Urine
100 ll of T1 phage were added to 400 ll of artificial urine
and incubated at 37C during 24 h. Samples were taken
after 0, 3, 6, 9, and 24 h and the phage titre was performed
according to Adams [10].
Epithelial Cells and Growth Conditions
Epithelial cell line from human bladder (TCC-SUP from
DSMZ) was grown on D-MEM, supplemented with 15% of
fetal bovine serum (FBS, Gibco-Invitrogen) and 1%
Streptomycin/Penicillin (Gibco-Invitrogen). Cells were
grown in 24 well microplates at 37C and 5% of CO2, until
they reached an 80% of confluence. A number of 1 9 105
cells per well, determined by tripan blue exclusion staining,
was achieved.
E. coli Adhesion to Epithelial Cells
The TCC-SUP epithelial cell monolayers were washed
with phosphate buffered saline (PBS 0.1 M, pH 7.4). After,
500 ll of E. coli 613 diluted suspensions (104 up to 109
CFUml-1) or 500 ll of PBS (control), were added to each
monolayer. Adhesion assays were performed during 30, 60,
120, and 180 min, at 37C and under agitation (120 rpm).
At each time point, the wells were washed three times with
PBS, to remove unattached bacteria. Bacteria were enu-
merated by CFU determination, after tripsinization of
epithelial cells. All experiments were carried out in
triplicate.
Phage Infection of Urothelium Adhered and Suspended
Bacteria
Urothelium was grown at 37C in 24 well ELISA plates
until a concentration of 105 cells/well, after which E. coli
were allowed to adhere for 2 h. Afterwards, the adhered
bacteria were phageinfected during 2 h varying the MOI
used (0.1 and 1) and varying also the phage infection
conditions (static and dynamic). The plates were incubated
at 37C and the efficacy of phage infection was assessed
through determination of the concentration of bacteria.
Phage infection of exponential E. coli cultures were also
performed in order to compare the lytic efficacy of adhered
against suspended E. coli. All experiments were carried out
in triplicate.
Results
Antibiotic and Bacteriophage Susceptibility
of the 69 Clinical Isolates of E. Coli
The susceptibility of the 69 clinical E. coli isolates is
presented in Fig. 1. The resistance profiles of the E. coli
clinical isolates revealed that more than 60 percent of the
strains were resistant to ampicillin (AMP). Furthermore,
the strains were most susceptible to nitrofurantoin (FD)
(Fig. 1). Based on these results, the 69 isolates were
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divided in two groups: the first containing the resistant
strains (Fig. 2a) and the second group containing the iso-
lates susceptible to the antibiotics tested (Fig. 2b) and
tested for susceptibility to three DSMZ culture collection
phages: T1, T4, and phiX174, respectively. Phage T1
showed aptitude to infecting the highest percentage of
antibiotic resistant E. coli strains (Fig. 2a) while phage T4
lysed a larger number of antibiotic susceptible isolates
(Fig. 2b). Overall the T1 and T4 phages were the most
efficient phages showing activity against 43.5 and 41.1% of
the clinical isolates tested whereas phage phiX174 exhib-
ited a narrower range of activity, being able to infect only
9.4% of the isolates tested. According to these results,
phage T1 was selected for further experiments since it was
capable of lysing the broadest range of hosts.
Growth of E. coli and Stability of Phage T1 in Urine
The growth characteristics of E. coli DSMZ 613, phage
T1’s host, in artificial urine were determined. This bacte-
rium has a doubling time of approximately 53 min and a
specific growth rate of 0.78 h-1. Stability tests performed
with phage T1 in artificial urine showed that the phage
remained stable for 24 h and maintained its infection
ability, as confirmed by plaque forming unit tests per-
formed after different periods of exposure to artificial urine
(data not shown).
Phage Infection of Bacteria Suspended or Adhered
to Urothelium
In vitro phage infection experiments of bacteria adhered to
the urothelium were performed under static and dynamic
(under the influence of shaking) conditions. Prior to the
phage infection experiments on E. coli cells, the phage
multiplicity of infection (MOI) was optimized. E. coli were
infected, under dynamic conditions (120 rpm), with five
different MOIs ranging from 0.01 up to 10 and cell lysis
was followed by optical density measurements (data not
shown). Two multiplicities of infection were selected for
all further experiments: 0.1 and 1, respectively and the
infection period selected was 2 h. Furthermore, two dif-
ferent E. coli concentrations which resulted in approxi-
mately 105 CFUml-1 of adhered cells after 60 min were
also selected for the adhesion and phage infection studies,
106 and 107 CFUml-1, respectively (data not shown). It is
important to have this concentration of adhered cells since
typically a urinary tract infection is characterized by a
positive uroculture of more than 105 CFUml-1[11, 12].
The reduction percentages of bacterial cells adhered to
urothelium (A columns in Figs. 3, 4) following phage
infection were compared with the reduction values
obtained with suspended cultures (S columns in Figs. 3, 4).
Under static conditions, cell reductions of both adhered and
suspended bacteria following phage infection were in
general very low. The use of different MOIs did not
influence greatly the average reduction percentages
obtained. However, it was clear that phages were slightly
more efficient in lysing suspended E. coli than those found
adhered to urothelium, independently on the inoculum
concentration used. The higher inoculum concentration
(107 CFUml-1) resulted in a higher percentage of cell
reduction clearly due to the presence of slightly more cells
Fig. 1 Susceptibility of the 69 clinical E. coli isolates to 8 antibiotics
(AMP ampicillin, NXM norfloxacin, AUG amoxicillin/clavulanate,
FD nitrofurantoin, SXT TMP-SMX, CP cephalothin, CIP ciproflox-
acin, TET tetracycline)
Fig. 2 Susceptibility of the 69 clinical E. coli isolates to bacteriophage T1, T4, and phiX174. Susceptibility of the: a antibiotic resistant and
b antibiotic susceptible strains to phages
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adhered to the urothelium than in the experiments where 106
CFUml-1 was used as inoculum. Although the reduction of
adhered cells by phages under static conditions was low, this
work evidences that phages can kill to some extent cells
adhered to urothelium. Comparatively to the phage experi-
ments carried out under static, under dynamic conditions the
phage was significantly more efficient in infecting E. coli
adhered to urothelium (Fig. 4). Under static infection con-
ditions, the average cell reduction percentages obtained,
using inoculum concentrations of 106 and 107 CFUml-1,
were approximately 10 and 20%, while under dynamic
conditions those percentages were about 30 and 35%
(compare Figs. 3, 4). Furthermore, like in the experiments
performed under static conditions, the differences obtained
using a MOI of 0.1 and 1.0 were insignificant.
Discussion
Urinary tract infections (UTI) are among the most common
bacterial infections affecting a large proportion of the
worldwide population. These infections are mainly caused
by E. coli that have the capacity to colonize and invade
epithelial cells [13]. Presumably, this tactic of invasion
allows the development of a cellular niche where micro-
organism can persist in a protected pathway [14] especially
against the action of the antibiotics, as already demon-
strated both in vitro and in vivo [15, 16]. In fact, the
physiological alterations of bacteria triggered by the sessile
mode of live can confer protection against antibiotics
[17–19]. Specifically it has already been shown that bac-
teria adhered to epithelium can be up to 100 times more
tolerant to antibiotics [19, 20]. In this study the authors
describe the use of bacteriophages to reduce the loads of
E. coli adhered to urothelium and evaluate their efficacy
after infection of cells using two different phage-host ratios
and under two distinct conditions, static, and shaken,
respectively. The results after the 2 h of phage treatment
were similar using an initial MOI of 0.1 or 1 since both
phage concentrations led to approximately the same per-
centage of cell reduction. Furthermore, phage T1 was
significantly more efficient in infecting E. coli adhered to
urothelium under shaken conditions most likely to an
enhancement of the contact between the phage and the
respective host. Contrarily to the infection of adhered
E. coli, where the efficacy of phage T1 was affected by the
application condition used (static or dynamic), the infec-
tion of planktonic cells with phage T1 under shaken and
non-shaken conditions was comparable. Although in the
present study, under static conditions, the adhered bacteria
showed to be less sensitive to the phages overall the effi-
cacy of phage T1 against adhered bacteria was similar to
the infection of planktonic cells. Thus, contrarily to anti-
biotics, which hardly remove bacteria from existing bio-
films [21], this study shows that phages are able to cause
cell lysis of biofilm bacteria.
Besides the ability of phage T1 to infect adhered and
planktonic E. coli cultures, this work also shows that
phages deposited in culture collection have the ability to
kill E. coli from different origins than the deposited host
since it was able, together with T4 and phiX174, to infect a
variety of antibiotic resistant clinical isolates.
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